<VariationArchive VariationID="583751" VariationName="NC_000006.12:g.(?_5404522)_(5404721_?)del" VariationType="Deletion" Accession="VCV000583751" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2018-10-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="563265" VariationID="583751">
      <GeneList>
        <Gene Symbol="FARS2" FullName="phenylalanyl-tRNA synthetase 2, mitochondrial" GeneID="10667" HGNC_ID="HGNC:21062" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="5249934" stop="5771583" display_start="5249934" display_stop="5771583" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="5261583" stop="5771815" display_start="5261583" display_stop="5771815" Strand="+" />
          </Location>
          <OMIM>611592</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000006.12:g.(?_5404522)_(5404721_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" innerStart="5404522" innerStop="5404721" display_start="5404522" display_stop="5404721" variantLength="200" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" innerStart="5404755" innerStop="5404954" display_start="5404755" display_stop="5404954" variantLength="200" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.(?_5404522)_(5404721_?)del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.(?_5404522)_(5404721_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.(?_5404755)_(5404954_?)del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.(?_5404755)_(5404954_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000006.12:g.(?_5404522)_(5404721_?)del AND Combined oxidative phosphorylation defect type 14" Accession="RCV000708020" Version="7">
        <ClassifiedConditionList TraitSetID="9027">
          <ClassifiedCondition DB="MedGen" ID="C4755312">Combined oxidative phosphorylation defect type 14</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22833457</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30634555</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9027" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17497" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Combined oxidative phosphorylation defect type 14</ElementValue>
                <XRef ID="MONDO:0013986" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 14</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COXPD14</ElementValue>
                <XRef Type="MIM" ID="614946" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of FARS2 deficiency ranges from the infantile-onset phenotype, characterized by epileptic encephalopathy with lactic acidosis and poor prognosis (70% of affected individuals), to the later-onset phenotype, characterized by spastic paraplegia, less severe neurologic manifestations, and longer survival (30% of affected individuals). To date FARS2 deficiency has been reported in 37 individuals from 25 families. Infantile-onset phenotype. Seizures are difficult to control and may progress quickly at an early age to intractable seizures with frequent status epilepticus; some children have hypsarrhythmia on EEG. All have developmental delay; most are nonverbal and unable to walk. Feeding difficulties are common. More than half of affected children die in early childhood. Later-onset phenotype. All affected individuals have spastic paraplegia manifested by weakness, spasticity, and exaggerated reflexes of the lower extremities associated with walking difficulties; some have developmental delay/intellectual disability; some have brief seizures that resolve over time.</Attribute>
                <XRef ID="NBK538658" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17455" />
                <XRef ID="17455" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30869852</ID>
                <ID Source="BookShelf">NBK538658</ID>
              </Citation>
              <XRef ID="319519" DB="Orphanet" />
              <XRef ID="C4755312" DB="MedGen" />
              <XRef ID="MONDO:0013986" DB="MONDO" />
              <XRef Type="MIM" ID="614946" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1609155" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="NM_006567.3_6_Deletion (exon 3)|MedGen:C3554168" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000837130" DateUpdated="2024-06-09" DateCreated="2018-10-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22833457</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30634555</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 3 of the FARS2 gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in FARS2 are known to be pathogenic (PMID: 22833457). A similar copy number variant has been observed in individual(s) with FARS2-related conditions (PMID: 30634555). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FARS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.(?_5404755)_(5404954_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554168" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1609155" TraitType="Disease" MappingType="XRef" MappingValue="C3554168" MappingRef="MedGen">
        <MedGen CUI="C4755312" Name="Combined oxidative phosphorylation defect type 14" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>